a) All patients (N = 2574) | Â | Â | Â |
---|---|---|---|
Variable | F-value | p-value | Estimate a |
≥ 50% reduction in overall pain VAS during the first 4 weeks | 158.6 | < 0.0001 | 13.32 |
Number of weeks unable to work in the last 12 months | 40.9 | < 0.0001 | -0.23 |
Overall pain VAS at baseline (per 20 mm) | 33.9 | < 0.0001 | -2.34 |
Any concomitant somatic disease at baseline | 30.5 | < 0.0001 | -5.86 |
SSI non-painful symptoms subscore at baseline | 18.0 | < 0.0001 | -3.49 |
Living alone | 13.8 | < 0.001 | -3.89 |
≥ 50% reduction in the SSI painful symptoms subscore during the first 4 weeks | 11.0 | < 0.001 | 6.22 |
Any baseline psychotropic medication | 7.9 | 0.005 | -2.93 |
Duration of depression (years) | 6.1 | 0.014 | -0.12 |
Mean KUSTA at baseline (per 20 mm) | 5.6 | 0.018 | 1.47 |
b) Patients with baseline pain VAS > 30 mm (N = 2053) | Â | Â | Â |
Variable | F-value | p-value | Estimate a |
≥ 50% reduction in overall pain VAS during the first 4 weeks | 151.4 | < 0.0001 | 14.74 |
Number of weeks unable to work in the last 12 months | 40.2 | < 0.0001 | -0.25 |
Any concomitant somatic disease at baseline | 22.1 | < 0.0001 | -5.98 |
SSI non-painful symptoms subscore at baseline | 16.0 | < 0.0001 | -3.54 |
Overall pain VAS at baseline (per 20 mm) | 15.0 | < 0.001 | -2.50 |
Living alone | 13.3 | < 0.001 | -4.24 |
Mean KUSTA at baseline (per 20 mm) | 9.9 | 0.002 | 2.36 |
≥ 50% reduction in the SSI painful symptoms subscore during the first 4 weeks | 8.7 | 0.003 | 5.84 |
Age | 4.1 | 0.044 | -0.09 |
Duration of Depression (years) | 3.9 | 0.048 | -0.10 |